What we know about SARS-CoV-2: recent research progress
WANG Chang-le1, WANG Lei2, HAO Ran3, QIAO Hong-xiu1, ZHAO Yan1, CHUAI Xia1
1. Department of Pathogenic Biology, Hebei Medical University, Shijiazhuang 050017,China; 2. Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017,China; 3. School of Nursing, Hebei Medical University, Shijiazhuang 050017,China
Abstract：SARS-CoV-2 is a novel member of the coronavirus family. The virus has caused disease in more than 18 million people worldwide, including respiratory, circulatory, reproductive, digestive and urinary symptoms. However, the first infected case was identified as unexplained pneumonia. SARS-CoV-2 has stronger infection and transmission ability than SARS-CoV, which caused a pneumonia epidemic in 2003. Many researchers have carried out extensive studies on SARS-CoV-2. They have focused on further elucidating the microbiological characteristics of this virus and have made gradual progress in developing vaccines, therapeutic antibodies and antiviral drugs. Our country has made remarkable achievements in vaccine research. In this review, we focus on recent research progress on the biological characteristics, origin, infection and host immune response, transmission and treatment of SARS-CoV-2.
王常乐, 王磊, 郝冉, 乔红秀, 赵艳, 揣侠. SARS-CoV-2的研究进展[J]. 中国人兽共患病学报, 2020, 36(10): 780-785.
WANG Chang-le, WANG Lei, HAO Ran, QIAO Hong-xiu, ZHAO Yan, CHUAI Xia. What we know about SARS-CoV-2: recent research progress. Chinese Journal of Zoonoses, 2020, 36(10): 780-785.
[1] Wu F,Zhao S,Yu B,et al.A new coronavirus associated with human respiratory disease in China[J]. Nature, 2020, 579(7798):265-269. DOI: 10.1038/s41586-020-2008-3 [2] Kim D, Lee JY, Yang JS, et al.The architecture of SARS-CoV-2 transcriptome[J]. Cell, 2020, 181(4):914-921. DOI: 10.1016/j.cell.2020.04.011 [3] Chan KH, Peiris JS, Lam SY, et al.The effects of temperature and relative humidity on the viability of the SARS coronavirus[J]. Adv Virol, 2011, 2011:734690. DOI: 10.1155/2011/734690 [4] Pastorino B, Touret F, Gilles M, et al.Evaluation of heating and chemical protocols for inactivating SARS-CoV-2[J/OL]. bioRxiv, 2020. DOI: 10.1101/2020.04.11.036855 [5] van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1[J]. N Engl of Med, 2020, 382(16):1564-1567. DOI: 10.1056/NEJMc2004973 [6] Setti L, Passarini F, Gennaro GD, et al.SARS-Cov-2 RNA found on particulate matter of bergamo in northern italy-first preliminary evidence[J/OL]. medRxiv, 2020. DOI: 10.1101/2020.04.15.20065995 [7] Zhou P,Yang XL,Wang XG,et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin[J]. Nature, 2020, 579(7798): 270-273. DOI: 10.1038/s41586-020-2012-7 [8] Zhou H, Chen X, Hu T, et al.A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein[J]. Curr Biol, 2020, 30(11):2196-2203. DOI: 10.1016/j.cub.2020.05.023 [9] Yu WB, Tang GD, Zhang L, et al.Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2) using whole genomic data[J]. Zool Res, 2020, 41(3):247-257. DOI: 10.24272/j.issn.2095-8137.2020.022 [10] Forster P, Forster L, Renfrew C, et al.Phylogenetic network analysis of SARS-CoV-2 genomes[J]. Proc Natl Acad Sci USA, 2020,117(17):9241-9243. DOI: 10.1073/pnas.2004999117 [11] Bao L,Deng W,Huang B,et al.The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice[J]. Nature, 2020, 583(7818):830-833. DOI: 10.1038/s41586-020-2312-y [12] Zou X, Chen K, Zou J, et al.Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection[J]. Front Med, 2020, 14(2):185-192. DOI: 10.1007/s11684-020-0754-0 [13] Fan Z, Chen L, Li J, et al.Clinical features of COVID-19 related liver damage[J]. Clin Gastroenterol Hepatol, 2020, 18(7):1561-1566. DOI: 10.1016/j.cgh.2020.04.002 [14] Zhang H, Kang Z, Gong H, et al.The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes[J/OL]. bioRxiv, 2020. DOI: 10.1101/2020.01.30.927806 [15] Li Z, Wu M, Yao J, et al.Caution on kidney dysfunctions of COVID-19 patients[J/OL]. medRxiv, 2020. DOI: 10.1101/2020.02.08.20021212 [16] Hoffmann M, Kleine-Weber H, Schroeder S, et al.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor[J]. Cell, 2020, 181(2):271-280. DOI: 10.1016/j.cell.2020.02.052 [17] Sungnak W, Huang N, Bécavin C, et al.SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes[J]. Nat Med, 2020, 26(5):681-687. DOI: 10.1038/s41591-020-0868-6 [18] Shang J, Wan Y, Luo C, et al.Cell entry mechanisms of SARS-CoV-2[J]. Proc Natl Acad Sci USA, 2020, 117(21):11727-11734. DOI: 10.1073/pnas.2003138117 [19] Liao M, Liu Y, Yuan J, et al.Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19[J]. Nat Med, 2020, 26(6):842-844. DOI: 10.1038/s41591-020-0901-9 [20] Huang C, Wang Y, Li X, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020,395(10223):497-506. DOI: 10.1016/S0140-6736(20)30183-5 [21] Chen N, Zhou M, Dong X, et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223):507-513. DOI: 10.1016/S0140-6736(20)30211-7 [22] Fu Y, Cheng Y, Wu Y.Understanding SARS-CoV-2-Mediated inflammatory responses: from mechanisms to potential therapeutic tools[J]. Virol Sin, 2020, 35(3):266-271. DOI: 10.1007/s12250-020-00207-4 [23] Wang PH, Cheng Y.Increasing host cellular receptor-angiotensin-converting enzyme 2(ACE2) expression by coronavirus may facilitate 2019-nCoV infection[J/OL]. bioRxiv, 2020. DOI: 10.1101/2020.02.24.963348 [24] Ziegler CGK, Allon SJ, Nyquist SK, et al.SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues[J]. Cell, 2020, 181(5):1016-1035. DOI: 10.1016/j.cell.2020.04.035 [25] Ni L, Ye F, Cheng ML, et al.Detection of SARS-CoV-2-Specific humoral and cellular immunity in COVID-19 convalescent individuals[J]. Immunity, 2020, 52(6):971-977. DOI: 10.1016/j.immuni.2020.04.023 [26] Grifoni A, Weiskopf D, Ramirez SI, et al.Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals[J]. Cell, 2020, 181(7):1489-1501. DOI: 10.1016/j.cell.2020.05.015 [27] 王春燕,王希营,金红.新型冠状病毒肺炎诊疗方案(试行第7版)[J]. 兰州大学学报(医学版), 2020, 46(2):1-7. DOI: 10.13885/j.issn.1000-2812.2020.02.001 [28] Zhou J, Li C, Liu X, et al.Infection of bat and human intestinal organoids by SARS-CoV-2[J]. Nat Med, 2020, 26(7):1077-1083. DOI: 10.1038/s41591-020-0912-6 [29] Liu Y, Ning Z, Chen Y, et al.Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals[J]. Nature, 2020, 582(7813):557-560. DOI: 10.1038/s41586-020-2271-3 [30] Oliveiros B, Caramelo L, Ferreira NC, et al.Role of temperature and humidity in the modulation of the doubling time of COVID-19 cases[J/OL]. Med Rxiv, 2020. DOI: 10.1101/2020.03.05.20031872 [31] Luo C, Yao L, Zhang L, et al.Possible transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a public bath center in Huai’an, Jiangsu Province, China[J]. JAMA Netw Open, 2020, 3(3):e204583. DOI: 10.1001/jamanetworkopen.2020.4583 [32] Yao Y, Pan J, Liu Z, et al.No association of COVID-19 transmission with temperature or UV radiation in Chinese cities[J]. Eur Respir J, 2020, 55(5):2000517. DOI: 10.1183/13993003.00517-2020 [33] 王瑜, 徐慕晗, 郑凡君, 等. 间充质干细胞在炎症性疾病治疗中的基础研究和临床应用[J]. 中国细胞生物学学报, 2019, 41(04):561-572. DOI: 10.11844/cjcb.2019.04.0003 [34] 刘广洋, 郑力搏, 王皓, 等. 间充质干细胞治疗新型冠状病毒肺炎的研究[J]. 药物评价研究, 2020, 43(03):372-377. DOI: 10.7501/j.issn.1674-6376.2020.03.002 [35] 孙瑶, 吕海金, 易小猛, 等. 间充质干细胞通过诱导M2型巨噬细胞治疗急性肺损伤[J]. 中山大学学报(医学版), 2019, 40(3):393-400. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2019.0056 [36] Plock JA, Schnider JT, Solari MG, et al.Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation[J]. Front Immunol, 2013, 4:175. DOI: 10.3389/fimmu.2013.00175 [37] Mo H, Zeng G, Ren X, et al.Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance[J]. Respirology, 2006, 11(1):49-53. DOI: 10.1111/j.1440-1843.2006.00783.x [38] Yuan M, Wu NC, Zhu X, et al.A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV[J]. Science, 2020, 368(6491):630-633. DOI: 10.1126/science.abb7269
2020, Vol. 36 
